Clinical trialNCT00569387CompletedPhase 2Interventional

Vaccine Study for Surgically Resected Pancreatic Cancer

SponsorNewLink Genetics CorporationEnrollment73Pancreatic Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To assess the response for subjects with pancreatic cancer that have undergone surgical resection and treatment with a vaccine given with chemotherapy and chemoradiation.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Charles J. Link, M.D.
NewLink Genetics Corporation
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Mayo Clinic - Scottsdale
Scottsdale, Arizona, United States
University of Southern California
Los Angeles, California, United States
University of California - Irvine
Orange, California, United States
California Pacific Medical Center
San Francisco, California, United States
University of Colorado
Aurora, Colorado, United States
University of Miami
Miami, Florida, United States
Northwestern University
Chicago, Illinois, United States
Evanston Northwestern Healthcare
Evanston, Illinois, United States
Indiana University
Indianapolis, Indiana, United States
Lahey Clinic
Burlington, Massachusetts, United States
University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
University of New Mexico
Albuquerque, New Mexico, United States
University Hospitals Case Western
Cleveland, Ohio, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Rhode Island Hospital
Providence, Rhode Island, United States
Roger Williams Medical Center
Providence, Rhode Island, United States
Baylor College of Medicine
Houston, Texas, United States
University of Texas Health Science Center
San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Algenpantucel-L

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2007
Primary completion: 31 Mar 2011
Completion: 31 Dec 2014
Last update posted: 28 May 2020
Registered enrollment: 73
Registry id: NCT00569387

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.